STAT1, signal transducer and activator of transcription 1, 6772
N. diseases: 531; N. variants: 41
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.716 | 0.440 | 2 | 190986921 | missense variant | G/A | snv |
|
Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
0.716 | 0.440 | 2 | 190986921 | missense variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases; Mental Disorders | 0.700 | 0 | |||||||||||
|
0.716 | 0.440 | 2 | 190986921 | missense variant | G/A | snv |
|
Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
0.716 | 0.440 | 2 | 190986921 | missense variant | G/A | snv |
|
Infections; Skin and Connective Tissue Diseases | 0.700 | 0 | |||||||||||
|
0.716 | 0.440 | 2 | 190986921 | missense variant | G/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 0 | |||||||||||
|
0.716 | 0.440 | 2 | 190986921 | missense variant | G/A | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 0 | |||||||||||
|
0.716 | 0.440 | 2 | 190986921 | missense variant | G/A | snv |
|
0.700 | 0 | ||||||||||||
|
0.882 | 2 | 190995129 | missense variant | G/T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.882 | 2 | 190995129 | missense variant | G/T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.882 | 2 | 190995129 | missense variant | G/T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.882 | 2 | 190995139 | missense variant | T/C | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.882 | 2 | 190995139 | missense variant | T/C | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.882 | 2 | 190995139 | missense variant | T/C | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
1.000 | 0.080 | 2 | 190979104 | splice region variant | A/G | snv | 0.23 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 2 | 191015488 | intron variant | C/T | snv | 4.8E-02 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.120 | 2 | 191009521 | intron variant | T/C | snv | 1.9E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.120 | 2 | 191009521 | intron variant | T/C | snv | 1.9E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.120 | 2 | 191009521 | intron variant | T/C | snv | 1.9E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.120 | 2 | 191009521 | intron variant | T/C | snv | 1.9E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.120 | 2 | 191009521 | intron variant | T/C | snv | 1.9E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.120 | 2 | 191009521 | intron variant | T/C | snv | 1.9E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
2 | 190971964 | intron variant | C/T | snv | 0.22 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
2 | 190977153 | intron variant | A/G | snv | 0.22 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 2 | 190978719 | non coding transcript exon variant | G/A | snv | 0.10 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.080 | 2 | 190975830 | missense variant | A/G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 |